Arcadia Biosciences, Inc. (RKDA) Operating margin 2016–2025
Arcadia Biosciences, Inc. (RKDA) operating margin by fiscal year — reported operating income divided by reported revenue.
-51.5%FY2025 · since FY2016: -584.1% → -51.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -51.5% | +20.8 pp |
| FY2024 | -72.3% | +64.7 pp |
| FY2023 | -137.0% | +51.8 pp |
| FY2022 | -188.8% | +335.2 pp |
| FY2021 | -524.0% | -364.9 pp |
| FY2020 | -159.0% | +1498.9 pp |
| FY2019 | -1657.9% | -505.6 pp |
| FY2018 | -1152.3% | -796.8 pp |
| FY2017 | -355.6% | +228.5 pp |
| FY2016 | -584.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice